Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F18%3A00100761" target="_blank" >RIV/00216224:14310/18:00100761 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68081707:_____/18:00488378 RIV/00159816:_____/18:00067441
Výsledek na webu
<a href="http://dx.doi.org/10.1038/onc.2017.392" target="_blank" >http://dx.doi.org/10.1038/onc.2017.392</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/onc.2017.392" target="_blank" >10.1038/onc.2017.392</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
Popis výsledku v původním jazyce
Metastasis accounts for most of cancer-related deaths. Paracrine signaling between tumor cells and the stroma induces changes in the tumor microenvironment required for metastasis. Transcription factor c-Myb was associated with breast cancer (BC) progression but its role in metastasis remains unclear. Here we show that increased c-Myb expression in BC cells inhibits spontaneous lung metastasis through impaired tumor cell extravasation. On contrary, BC cells with increased lung metastatic capacity exhibited low c-Myb levels. We identified a specific inflammatory signature, including Ccl2 chemokine; that was expressed in lung metastatic cells but was suppressed in tumor cells with higher c-Myb levels. Tumor cell-derived Ccl2 expression facilitated lung metastasis and rescued trans-endothelial migration of c-Myb overexpressing cells. Clinical data show that the identified inflammatory signature, together with a MYB expression, predicts lung metastasis relapse in BC patients. These results demonstrate that the c-Myb-regulated transcriptional program in BCs results in a blunted inflammatory response and consequently suppresses lung metastasis.
Název v anglickém jazyce
Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding
Popis výsledku anglicky
Metastasis accounts for most of cancer-related deaths. Paracrine signaling between tumor cells and the stroma induces changes in the tumor microenvironment required for metastasis. Transcription factor c-Myb was associated with breast cancer (BC) progression but its role in metastasis remains unclear. Here we show that increased c-Myb expression in BC cells inhibits spontaneous lung metastasis through impaired tumor cell extravasation. On contrary, BC cells with increased lung metastatic capacity exhibited low c-Myb levels. We identified a specific inflammatory signature, including Ccl2 chemokine; that was expressed in lung metastatic cells but was suppressed in tumor cells with higher c-Myb levels. Tumor cell-derived Ccl2 expression facilitated lung metastasis and rescued trans-endothelial migration of c-Myb overexpressing cells. Clinical data show that the identified inflammatory signature, together with a MYB expression, predicts lung metastasis relapse in BC patients. These results demonstrate that the c-Myb-regulated transcriptional program in BCs results in a blunted inflammatory response and consequently suppresses lung metastasis.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10601 - Cell biology
Návaznosti výsledku
Projekt
<a href="/cs/project/GJ17-08985Y" target="_blank" >GJ17-08985Y: Prozánětlivá signalizace pod kontrolou proteinu c-Myb v bazálních prsních karcinomech</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Oncogene
ISSN
0950-9232
e-ISSN
—
Svazek periodika
37
Číslo periodika v rámci svazku
8
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
11
Strana od-do
1020-1030
Kód UT WoS článku
000425905700005
EID výsledku v databázi Scopus
—